Friday 6 November 2026
Export ALB’s income statement to Excel — free account
Albemarle Corporation
ALB Basic Materials Specialty Chemicals
Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024.
- Revenue
- +18.8%
- EPS
- +225.6%
- Free cash flow
- +708.4%
- Total debt
- −48.1%
Quarter to September 2026, against a year earlier
98.52
0.15
+0.15%
Follow ALB
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 281.31 | 24.26 |
P/S ratio |
3.24 | 3.85 | 2.70 | 2.03 | |
P/FCF ratio |
22.95 | 34.78 | 11.79 | 9.24 | |
P/Operating CF |
42.84 | 61.11 | 22.43 | 17.58 | |
P/B ratio |
2.21 | 2.69 | 1.92 | 1.45 | |
Price to Tangible BV |
2.85 | 3.43 | 2.41 | 1.81 | |
EV/Sales |
3.54 | 3.99 | 2.74 | 2.03 | |
EV/EBITDA |
38.54 | 32.16 | 15.05 | 9.91 | |
EV/Operating CF |
14.21 | 20.30 | 8.98 | 6.95 | |
EV/FCF |
25.12 | 36.09 | 11.97 | 9.26 | |
Quick Ratio |
1.29 | 1.11 | 1.25 | 1.44 | |
Current Ratio |
2.23 | 2.07 | 2.09 | 2.34 | |
Net Debt/EBITDA |
(29.35) | 2.02 | 0.40 | 0.11 | |
Debt/Assets |
19.50% | 12.43% | 11.80% | 11.70% | |
Debt/Equity |
0.33 | 0.19 | 0.18 | 0.17 | |
Asset Turnover |
0.31 | 0.34 | 0.36 | 0.37 | |
Operating CF/Net income |
(0.85) | 1.25 | 1.62 | 0.00 | |
Capex/Depreciation |
(0.91) | (0.63) | (0.46) | 0.00 | |
Interest Coverage |
(3.76) | 7.05 | 14.65 | 5.33 | |
Research and Development Expense of Revenue |
0.85% | 0.64% | 0.21% | 0.53% | |
Selling, General and Administrative Expense of Revenue |
10.89% | 9.62% | 7.25% | 8.78% | |
Intangible Assets out of Total Assets |
0.10 | 0.11 | 0.11 | 0.10 | |
Share Based Compensation of Revenue |
0.86% | 0.55% | 0.39% | 0.62% | |
Graham Net Nets |
(0.16) | (0.08) | (0.09) | (0.08) | |
Graham Number |
0.00 | 0.00 | 27.56 | 84.48 | |
Earnings Yield |
(4.07%) | (1.89%) | 0.36% | 4.12% | |
Free Cash Flow Yield |
4.36% | 2.87% | 8.48% | 10.83% | |
Revenue per Share |
12.14 | 12.12 | 14.78 | 13.16 | |
Operating CF per Share |
3.30 | 2.94 | 6.02 | 0.00 | |
Capex per Share |
(1.26) | (0.84) | (0.61) | 0.00 | |
Free Cash Flow per Share |
2.04 | 2.10 | 5.41 | 0.00 | |
Cash per Share |
13.75 | 9.25 | 13.83 | 15.64 | |
Shareholders Equity per Share |
83.13 | 85.77 | 89.30 | 91.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
83.13 | 85.77 | 89.30 | 91.69 | |
Free Cash Flow |
240.26 | 247.57 | 638.27 | — | |
Working Capital |
2,210.10 | 1,683.25 | 2,053.10 | 2,426.71 | |
Capital Expenditures |
(148.22) | (98.68) | (71.73) | — | |
Net Current Asset Value |
(2,584.61) | (1,772.28) | (1,427.04) | (1,030.52) | |
EV/EBIT |
0.00 | 0.00 | 64.16 | 20.28 | |
Capex to Sales |
0.10 | 0.07 | 0.04 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 63.19 | 20.22 | |
| Other line items | |||||
Average Receivables |
839.60 | 733.67 | 803.71 | 796.31 | |
Average Payables |
928.71 | 925.87 | 987.22 | — | |
Average Inventory |
1,340.90 | 1,501.66 | 1,512.74 | 1,462.61 | |
Average Assets |
16,491.93 | 16,069.42 | 16,598.51 | 16,615.80 | |
Average Common Equity |
7,755.47 | 7,956.12 | 8,281.31 | 8,309.44 |
Columns are period end dates · fundamentals updated 4 Nov 2026